SEC Form 4 · accession 0001171000-15-000012
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Heffernan
Officer — Chief Executive Officer · Director
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 7:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 8, 2015 | A | 7,250 | $0.125 | A | 7,250 | D | |
| Ordinary SharesF1 | holding | — | — | — | 234,383 | I | By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C> |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person and his spouse share voting and dispositive power with respect to the reported securities.